Preparative resolution of gatifloxacin enantiomers with pre-column esterification strategy and comparing their enantioselectivity to bacteria and antibody.
- Author:
Chi Jian ZHANG
1
;
Hong Tao LEI
1
;
Xiao Long HUANG
1
;
Ying Ju LIU
2
;
Kai CAI
3
;
Zhen Lin XU
1
;
Yuan Ming SUN
1
Author Information
- Publication Type:Letter
- MeSH: Anti-Bacterial Agents; chemistry; pharmacology; Escherichia coli; drug effects; Esterification; Fluoroquinolones; chemistry; pharmacology; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship
- From: Biomedical and Environmental Sciences 2015;28(2):157-160
- CountryChina
- Language:English
- Abstract: Gatifloxacin (GFX) is a kind of chiral fluoroquinolones compound due to the methyl group at the C-3 position of the piperazine ring[1]. Although the enantiomers of GFX show similar levels of antimicrobial activity and pharmacokinetics[2], the other biological activities (i.e., toxicity or enantioselective recognition to various receptors in vivo) of GFX enantiomers have not yet been studied. With this in mind, we developed a rapid and cost-effective high performance liquid chromatographic (HPLC) separation procedure for GFX enantiomers with a pre-column esterification strategy. With significant enhancement of drug solubility and optimization for chromatographic conditions, the proposed method was scaled up to preparative HPLC to obtain optical active S-(-)- and R-(+)-GFX. The antibacterial activities of GFX enantiomers after preparative separation were further verified by measuring the Minimum Inhibitory Concentration (MIC) values against Escherichia coli ATCC 25922. In addition, the binding selectivity of GFX enantiomers to protein receptor were evaluated by antibody using enzyme-linked immunosorbent assay (ELISA) for the first time.
